Risk of cardiovascular events with cyclin-dependent kinases 4 and 6 (CDK 4/6) inhibitors among patients with metastatic breast cancer: A systematic review and network meta-analysis

被引：0
|
作者：
Liu, Yi-Shao [1 ]
Dong, Kevin [1 ]
Park, Chanhyun [2 ]
机构：
[1] Univ Texas Austin, Austin, TX USA
[2] Univ Texas Austin, Coll Pharm, Hlth Outcomes Div, Austin, TX USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1218
引用
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [1] Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis
    Liu, Yi-Shao
    Dong, Kevin
    Park, Chanhyun
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (11)
  • [2] A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
    Zhang, Jialin
    Xu, Xinyu
    Zhou, Yeyue
    Su, Jingyang
    Wang, Jue
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [3] Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis
    Bas, Onur
    Erul, Enes
    Guven, Deniz Can
    Aksoy, Sercan
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 9071 - 9078
  • [4] Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer A Systematic Review and Meta-analysis
    Li, Jinming
    Huo, Xingfa
    Zhao, Fuxing
    Ren, Dengfeng
    Ahmad, Raees
    Yuan, Xinyue
    Du, Feng
    Zhao, Jiuda
    JAMA NETWORK OPEN, 2020, 3 (10) : E2020312
  • [5] Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis
    Onur Bas
    Enes Erul
    Deniz Can Guven
    Sercan Aksoy
    Supportive Care in Cancer, 2022, 30 : 9071 - 9078
  • [6] Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
    Fradley, Michael G.
    Nguyen, Nam H. K.
    Madnick, David
    Chen, Yiqing
    DeMichele, Angela
    Makhlin, Igor
    Dent, Susan
    Lefebvre, Benedicte
    Carver, Joseph
    Upshaw, Jenica N.
    DeRemer, David
    Ky, Bonnie
    Guha, Avirup
    Gong, Yan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (12):
  • [7] Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis
    Shohdy, Kyrillus S.
    Lasheen, Shaimaa
    Kassem, Loay
    Abdel-Rahman, Omar
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (11) : 337 - 347
  • [8] Association between cyclin-dependent kinase 4/6 inhibitors and nephrotoxicity in patients with breast cancer: A Systematic Review and meta-analysis
    Cui, Jiayong
    Sun, Jinquan
    Zhou, Xueying
    Li, Yi
    Zhao, Jiuda
    Shen, Guoshuang
    ISCIENCE, 2024, 27 (12)
  • [9] Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
    Lasheen, Shaimaa
    Shohdy, Kyrillus S.
    Kassem, Loay
    Abdel-Rahman, Omar
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (09) : 851 - 856
  • [10] Cardiovascular Toxicities of Cyclin Dependent Kinase (cdk) 4/6 Inhibitors in Metastatic Breast Cancer Patients
    Fradley, Michael G.
    Nam Nguyen
    Chen, Yiqing
    Guha, Avirup
    Upshaw, Jenica N.
    Ky, Bonnie
    Gong, Yan
    CIRCULATION, 2020, 142
12345